In this study, we have delineated some of the mechanisms by which FOXM1 inhibitors suppress breast cancer cells and illuminated methods by which the cancer cells change their gene regulations and signaling when they progress from sensitive to acquired resistance upon prolonged exposure to these inhibitors. The gene discussed is FOXM1; the disease is cancer.